1 | 10% Metronidazole Ointment (Synonym: ROSADAN) | 1件: Metronidazole Metronidazole (Synonym: Rosaclear System) | 3件: D00409
D00409
(Name: ROSADAN),
D05016
,
D05017
| - | - | 1件: 96 96 |
2 | 11C-flumazenil (Synonym: Romazicon (TN)) | 1件: Flumazenil Flumazenil (Synonym: Romazicon) | 1件: D00697
D00697
(Name: Romazicon (TN)) | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 206 206 |
3 | 11C]flumazenil (Synonym: Romazicon (TN)) | 1件: Flumazenil Flumazenil (Synonym: Romazicon) | 1件: D00697
D00697
(Name: Romazicon (TN)) | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 13 13 |
4 | 1500mg mesalazine pellets (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
5 | 18F-RO6958948 | - | - | - | - | 3件: 5 5, 7, 127 |
6 | 250mg mesalazine pellets (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
7 | 500mg mesalazine pellets (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
8 | 750mg mesalazine pellets (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
9 | [18F]flumazenil (Synonym: Romazicon (TN)) | 1件: Flumazenil Flumazenil (Synonym: Romazicon) | 1件: D00697
D00697
(Name: Romazicon (TN)) | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 206 206 |
10 | ACT-050089 (Ro 61-0612) | - | - | - | - | 1件: 86 86 |
11 | Amoxicillin, metronidazole and doxycycline (Synonym: ROSADAN) | 3件: Amoxicillin Amoxicillin, Doxycycline, Metronidazole (Synonym: Rosaclear System) | 11件: D00229
D00229
,
D00307
,
D00409
(Name: ROSADAN),
D02129
,
D02925
,
D03903
,
D03904
,
D05016
,
D05017
,
D07452
,
D07876
| - | - | 1件: 97 97 |
12 | Azathioprine OR Mesalazine (Synonym: Rowasa (TN)) | 2件: Azathioprine Azathioprine, Mesalazine (Synonym: Rowasa) | 3件: D00238
D00238
,
D00377
(Name: Rowasa (TN)),
D03033
| - | - | 1件: 96 96 |
13 | Azithromycin + Metronidazole (Synonym: ROSADAN) | 2件: Azithromycin Azithromycin, Metronidazole (Synonym: Rosaclear System) | 6件: D00409
D00409
(Name: ROSADAN),
D02134
,
D05016
,
D05017
,
D06390
,
D07486
| - | - | 1件: 96 96 |
14 | Behavioral: Role of dopamine | 1件: Dopamine Dopamine | 2件: D00633
D00633
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
15 | Benznidazole (Synonym: Rochagan (TN)) | 1件: Benznidazole Benznidazole | 1件: D02489
D02489
(Name: Rochagan (TN)) | - | - | 1件: 65 65 |
16 | BMS Drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) (Synonym: Ropion (TN)) | 5件: Digoxin Digoxin, Flurbiprofen, Midazolam, Montelukast, Omeprazole | 13件: D00298
D00298
,
D00330
,
D00455
,
D00529
,
D00550
,
D00696
,
D01207
,
D01475
(Name: Ropion (TN)),
D02290
,
D05028
,
D05259
,
D05261
,
D08229
| 25件: ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP4A, ATP4B, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, PTGS1, PTGS2 💬 | 49件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 |
17 | BMS-986089-01 (RO7239361) , anti-myostatin | - | - | - | - | 1件: 113 113 |
18 | BMS-986089-01 (RO7239361) Injections, 15 mg/Syringe (21.4 mg/mL) | - | - | - | - | 1件: 113 113 |
19 | BMS-986089-01 (RO7239361) Injections, 35 mg/Syringe (50 mg/mL) | - | - | - | - | 1件: 113 113 |
20 | BMS-986089-01 (RO7239361) Injections, 50 mg/Syringe (71.4 mg/mL) | - | - | - | - | 1件: 113 113 |
21 | BMS-986089-01 (RO7239361) Injections, 7.5 mg/Syringe (10.7 mg/mL) | - | - | - | - | 1件: 113 113 |
22 | BMS-986089-01 (RO7239361), anti-myostatin | - | - | - | - | 1件: 113 113 |
23 | Butyrate enemas + routine management | 1件: Butyric Acid Butyric Acid | 1件: D05866
D05866
| - | - | 1件: 291 291 |
24 | C5 inh MAb, SKY59, RO/CH7092230 | - | - | - | - | 2件: 62 62, 109 |
25 | Calcitriol (Synonym: Rocaltrol (TN)) | 1件: Calcitriol Calcitriol (Synonym: Rocaltrol Oral Solution 1mcg/ml) | 1件: D00129
D00129
(Name: Rocaltrol (TN)) | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 9件: 18 18, 37, 46, 49, 66, 96, 158, 235, 326 |
26 | Calcitriol & Calcium (Synonym: Rocaltrol (TN)) | 2件: Calcitriol Calcitriol (Synonym: Rocaltrol Oral Solution 1mcg/ml), Calcium (Synonym: Multi Rol) | 1件: D00129
D00129
(Name: Rocaltrol (TN)) | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 235 235 |
27 | Calcium rosuvastatin | 2件: Calcium Calcium (Synonym: Multi Rol), Rosuvastatin | 2件: D01915
D01915
(Name: Rosuvastatin calcium),
D08492
(Name: Rosuvastatin) | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 79 79 |
28 | Ceftriaxone (Synonym: Rocephin (TN)) | 1件: Ceftriaxone Ceftriaxone (Synonym: Rocephin Pws 2gm/vial) | 2件: D00924
D00924
(Name: Rocephin (TN)),
D07659
| - | - | 3件: 2 2, 6, 97 |
29 | Crestor Tablets (calcium rosuvastatin) Film-Coated tablets | 2件: Calcium Calcium (Synonym: Multi Rol), Rosuvastatin | 2件: D01915
D01915
(Name: Rosuvastatin calcium),
D08492
(Name: Rosuvastatin) | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 79 79 |
30 | Delayed and extended release mesalazine (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
31 | Delayed Release 6MP or Calcitriol vs. Purinethol (Synonym: Rocaltrol (TN)) | 1件: Calcitriol Calcitriol (Synonym: Rocaltrol Oral Solution 1mcg/ml) | 1件: D00129
D00129
(Name: Rocaltrol (TN)) | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 96 96 |
32 | Dexmedetomidine with ropivacaine | 2件: Dexmedetomidine Dexmedetomidine, Ropivacaine | 4件: D00514
D00514
,
D01205
,
D04048
(Name: Ropivacaine hydrochloride),
D08490
(Name: Ropivacaine) | 8件: ADRA2A ADRA2A, ADRA2B, ADRA2C, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 5件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬 | 1件: 70 70 |
33 | Diagnostic Test: [18F]-RO6958948 | - | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
34 | Diagnostic Test: Elecsys (Roche) Abeta42, Ttau and Ptau | - | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
35 | Diagnostic Test: PET with [11C]Flumazenil (Synonym: Romazicon (TN)) | 1件: Flumazenil Flumazenil (Synonym: Romazicon) | 1件: D00697
D00697
(Name: Romazicon (TN)) | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 13 13 |
36 | Diagnostic Test: Rey-Osterrieth Complex Figure Test (ROCFT) | - | - | - | - | 1件: 6 6 |
37 | Diagnostic Test: Rotational thromboelastometry | - | - | - | - | 2件: 86 86, 88 |
38 | Diagnostic Test: Rotterdam Handicap Scale (RHS) (Questionnaire) | - | - | - | - | 3件: 3 3, 15, 256 |
39 | Diagnostic Test: Routine MRI scan | - | - | - | - | 1件: 75 75 |
40 | Dopamine Agonists (pramipexole, ropirinole) | 2件: Dopamine Dopamine, Pramipexole | 4件: D00559
D00559
,
D00633
,
D05575
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
41 | Emicizumab (ACE910, RO5534262) | 1件: Emicizumab Emicizumab | 1件: D10821
D10821
| 2件: F10 F10, F9 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 |
42 | EU-approved RoActemra | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
43 | Flumazenil (Synonym: Romazicon (TN)) | 1件: Flumazenil Flumazenil (Synonym: Romazicon) | 1件: D00697
D00697
(Name: Romazicon (TN)) | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 5件: 6 6, 13, 17, 18, 206 |
44 | FLURBIPROFEN (Synonym: Ropion (TN)) | 1件: Flurbiprofen Flurbiprofen | 3件: D00330
D00330
,
D01475
(Name: Ropion (TN)),
D02290
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 3件: 13 13, 21, 46 |
45 | Gamma-secretase/Notch signalling pathway inhibitor RO4929097 | - | - | - | - | 1件: 74 74 |
46 | GDC-0853 RO7010939 | - | - | - | - | 3件: 13 13, 46, 49 |
47 | GLYCYRRHIZA GLABRA ROOT | 1件: Glycyrrhiza glabra Glycyrrhiza glabra (Synonym: Glycyrrhiza Glabra Rhizome/root) | - | - | - | 1件: 97 97 |
48 | GM-CSF, fosfomycin and metronidazole (Synonym: ROSADAN) | 2件: Fosfomycin Fosfomycin, Metronidazole (Synonym: Rosaclear System) | 7件: D00409
D00409
(Name: ROSADAN),
D00925
,
D02187
,
D02188
,
D04253
,
D05016
,
D05017
| - | - | 1件: 97 97 |
49 | Herbal Medicinal Mixture (Roucongrong, Heshouwu etc.) | 1件: Reynoutria multiflora root Reynoutria multiflora root | - | - | - | 1件: 6 6 |
50 | HP-3000 (ropinirole hydrochloride patch) | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
51 | HP-3000(ropinirole hydrochloride patch) | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
52 | Humira 40 mg injekcní roztok v predplnené injekcní stríkacce | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
53 | HYDROCORTISONE ROUSSEL | 1件: Hydrocortisone Hydrocortisone (Synonym: Rodan and Fields Soothe) | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 |
54 | IDEC-C2B8, Ro 45-2294 | - | - | - | - | 1件: 64 64 |
55 | IgG IL2/RO7049665 | - | - | - | - | 1件: 95 95 |
56 | Interferon Alfa-2A (Synonym: Roferon A (TN)) | 2件: Interferon alfa Interferon alfa, Interferon alfa-2a (Synonym: Roferon A Sterile Pws 18m Unit/vial) | 2件: D00745
D00745
(Name: Roferon A (TN)),
D03305
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 56 56 |
57 | Liberase Enzyme (Roche) | - | - | - | - | 2件: 85 85, 229 |
58 | LY03003 ( Rotigotine, extended-release microspheres) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
59 | LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
60 | LY03003( the name of rotigotine) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
61 | LY03003(Rotigotine,extended-release microspheres) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
62 | Magnesium with ropivacaine | 2件: Magnesium Magnesium (Synonym: Body Rox), Ropivacaine | 2件: D04048
D04048
(Name: Ropivacaine hydrochloride),
D08490
(Name: Ropivacaine) | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 70 70 |
63 | Mesalazine (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 3件: 46 46, 96, 97 |
64 | Mesalazine (3,600 mg) (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
65 | Mesalazine (Asacol®) (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
66 | Mesalazine (Mesalamine) (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 96 96 |
67 | Mesalazine - TID 1000 mg (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
68 | Mesalazine - TID 2x 500 mg (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
69 | Mesalazine 1000 mg gastro-resistant tablets (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
70 | Mesalazine 250Mg (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
71 | Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet (Synonym: Rowasa (TN)) | 2件: Mesalazine Mesalazine (Synonym: Rowasa), Nitazoxanide | 2件: D00377
D00377
(Name: Rowasa (TN)),
D02486
| - | - | 1件: 97 97 |
72 | Mesalazine 4G Enema (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
73 | Mesalazine 500 mg gastro-resistant tablets (Salofa (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
74 | Mesalazine 500 mg gastro-resistant tablets (Salofalk® 500 mg) (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
75 | Mesalazine EC 500 mg (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 96 96 |
76 | Mesalazine Enema (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
77 | Mesalazine liquid enema (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
78 | Mesalazine slow-release granules (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
79 | Mesalazine Sustained-Release Tablets (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 96 96 |
80 | Mesalazine tablet (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
81 | Mesalazine tablets (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 96 96 |
82 | Mesalazine with hydrocortisone sodium succinate (Synonym: Rowasa (TN)) | 2件: Hydrocortisone Hydrocortisone (Synonym: Rodan and Fields Soothe), Mesalazine (Synonym: Rowasa) | 2件: D00088
D00088
,
D00377
(Name: Rowasa (TN)) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
83 | Mesalazine, Tripterygium glycosides (Synonym: Rowasa (TN)) | 2件: Mesalazine Mesalazine (Synonym: Rowasa), Tripterygium wilfordii whole | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 96 96 |
84 | METRONIDAZOLE (Synonym: ROSADAN) | 1件: Metronidazole Metronidazole (Synonym: Rosaclear System) | 3件: D00409
D00409
(Name: ROSADAN),
D05016
,
D05017
| - | - | 8件: 46 46, 51, 63, 94, 95, 96, 97, 291 |
85 | Metronidazole capsule 50 mg (Synonym: ROSADAN) | 1件: Metronidazole Metronidazole (Synonym: Rosaclear System) | 3件: D00409
D00409
(Name: ROSADAN),
D05016
,
D05017
| - | - | 1件: 97 97 |
86 | Metronidazole Oral (Synonym: ROSADAN) | 1件: Metronidazole Metronidazole (Synonym: Rosaclear System) | 3件: D00409
D00409
(Name: ROSADAN),
D05016
,
D05017
| - | - | 1件: 96 96 |
87 | MINOXIDIL (Synonym: Rogaine (TN)) | 1件: Minoxidil Minoxidil (Synonym: Womens Rogaine Unscented) | 1件: D00418
D00418
(Name: Rogaine (TN)) | 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 1件: 179 179 |
88 | MMX mesalamine/ mesalazine (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
89 | MMX Mesalamine/Mesalazine (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
90 | MMX Mesalamine/Mesalazine (High Dose) (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
91 | MMX Mesalamine/Mesalazine (Low Dose) (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
92 | Montelukast, Flurbiprofen, Midazolam, Digoxin, Pravastatin and BMS-986142 (Synonym: Ropion (TN)) | 6件: BMS-986142 BMS-986142, Digoxin, Flurbiprofen, Midazolam, Montelukast, Pravastatin | 11件: D00298
D00298
,
D00330
,
D00529
,
D00550
,
D00696
,
D00893
,
D01475
(Name: Ropion (TN)),
D02290
,
D05028
,
D08229
,
D08410
| 24件: ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HMGCR, PTGS1, PTGS2 💬 | 49件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis - DNA adducts, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Terpenoid backbone biosynthesis, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 |
93 | Ocrelizumab (Roche, Switzerland) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
94 | Oral roflumilast | 1件: Roflumilast Roflumilast | 1件: D05744
D05744
(Name: Roflumilast) | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 299 299 |
95 | Other: Empiric use of Calcium Carbonate and Calcitriol (Synonym: Rocaltrol (TN)) | 4件: Calcitriol Calcitriol (Synonym: Rocaltrol Oral Solution 1mcg/ml), Calcium (Synonym: Multi Rol), Calcium carbonate (Synonym: Rolaids Ultra Strength- Mint), Carbonate ion | 3件: D00129
D00129
(Name: Rocaltrol (TN)),
D00932
,
D10802
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 235 235 |
96 | Other: Mesalazine (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
97 | Other: PTH based Calcium Carbonate and Calcitriol repletion (Synonym: Rocaltrol (TN)) | 3件: Calcitriol Calcitriol (Synonym: Rocaltrol Oral Solution 1mcg/ml), Calcium (Synonym: Multi Rol), Carbonate ion | 1件: D00129
D00129
(Name: Rocaltrol (TN)) | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 235 235 |
98 | Other: Rosemary essential oil | 1件: Rosemary Rosemary | - | - | - | 1件: 51 51 |
99 | Other: Rotigotine | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
100 | Other: Routine | - | - | - | - | 1件: 240 240 |
101 | Other: routine management | - | - | - | - | 1件: 291 291 |
102 | Other: routine therapy | - | - | - | - | 1件: 299 299 |
103 | Other: Transthoracic echocardiography at rest, during PLR, HG and CPX (including blood gas analysis in both groups). Additionally Fallot patients will undergo routine blood testings. | - | - | - | - | 1件: 215 215 |
104 | Overencapsulated mesalazine tablets (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
105 | PET with 11C-Flumazenil (Synonym: Romazicon (TN)) | 1件: Flumazenil Flumazenil (Synonym: Romazicon) | 1件: D00697
D00697
(Name: Romazicon (TN)) | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 13 13 |
106 | Pramipexole or ropinirole | 2件: Pramipexole Pramipexole, Ropinirole | 4件: D00559
D00559
,
D00784
(Name: Ropinirole hydrochloride),
D05575
,
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
107 | PRO145223 (RO5490261) | - | - | - | - | 1件: 97 97 |
108 | PZN 8881655(RochePharma AG) | - | - | - | - | 1件: 85 85 |
109 | R-roscovitine | 1件: Seliciclib Seliciclib (Synonym: R-roscovitine) | - | - | - | 1件: 75 75 |
110 | RAD001 round tablets | - | - | - | - | 1件: 158 158 |
111 | Ramelteon (Synonym: Rozerem (TN)) | 1件: Ramelteon Ramelteon (Synonym: Rozerem) | 1件: D02689
D02689
(Name: Rozerem (TN)) | 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 3件: 6 6, 8, 46 |
112 | Rapamycin-calcitriol combination (Synonym: Rocaltrol (TN)) | 2件: Calcitriol Calcitriol (Synonym: Rocaltrol Oral Solution 1mcg/ml), Sirolimus | 2件: D00129
D00129
(Name: Rocaltrol (TN)),
D00753
| 2件: MTOR MTOR, VDR 💬 | 55件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Mineral absorption, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Tuberculosis, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 158 158 |
113 | Recombinant human growth hormone + rosiglitazone | 2件: Rosiglitazone Rosiglitazone, Somatotropin | 3件: D00596
D00596
(Name: Rosiglitazone maleate),
D02691
,
D08491
(Name: Rosiglitazone) | 2件: GHR GHR, PPARG 💬 | 16件: AMPK signaling pathway AMPK signaling pathway, Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Huntington disease, JAK-STAT signaling pathway, Lipid and atherosclerosis, Longevity regulating pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 265 265 |
114 | Riluzole Oral Soluble film (ROSF) 50 mg | 1件: Riluzole Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 |
115 | RO | - | - | - | - | 1件: 6 6 |
116 | Ro 001-9265 | - | - | - | - | 1件: 41 41 |
117 | Ro 001-9265/F02 | - | - | - | - | 1件: 41 41 |
118 | RO 001-9265/F02-01 | - | - | - | - | 1件: 46 46 |
119 | Ro 001-9265/F03 | - | - | - | - | 1件: 41 41 |
120 | Ro 001-9265/F04 | - | - | - | - | 1件: 41 41 |
121 | Ro 002-9893/F02 | - | - | - | - | 1件: 46 46 |
122 | Ro 106-1443 | - | - | - | - | 1件: 49 49 |
123 | Ro 45-2294 | - | - | - | - | 1件: 46 46 |
124 | Ro 47-0203 | - | - | - | - | 4件: 51 51, 85, 86, 88 |
125 | Ro 47-0203 / ACT-050088 | - | - | - | - | 1件: 86 86 |
126 | Ro 48-77533 | - | - | - | - | 1件: 46 46 |
127 | Ro 487-533/F01 | - | - | - | - | 1件: 271 271 |
128 | Ro 487-5733/F01 | - | - | - | - | 1件: 271 271 |
129 | RO 487-7533 | - | - | - | - | 1件: 46 46 |
130 | Ro 487-7533/F01 | - | - | - | - | 3件: 46 46, 107, 271 |
131 | Ro 487-7533/F10 | - | - | - | - | 2件: 46 46, 107 |
132 | Ro 487-7533/F10-02 | - | - | - | - | 1件: 46 46 |
133 | Ro 487-7533/F10-04 | - | - | - | - | 4件: 41 41, 46, 51, 107 |
134 | Ro 491-7523/F18 | - | - | - | - | 1件: 206 206 |
135 | Ro 491-7523/F19 | - | - | - | - | 1件: 206 206 |
136 | RO 496-4913 | - | - | - | - | 2件: 46 46, 49 |
137 | Ro 496-4913/F03 | - | - | - | - | 2件: 13 13, 46 |
138 | Ro 496-4913/F07 | - | - | - | - | 1件: 13 13 |
139 | Ro 533-3787/F01-06 | - | - | - | - | 1件: 11 11 |
140 | Ro 549-0261/F04 | - | - | - | - | 1件: 97 97 |
141 | Ro 549-0261/F04-02 | - | - | - | - | 1件: 96 96 |
142 | Ro 549-0261/F08-02 | - | - | - | - | 1件: 96 96 |
143 | RO 551-6922 | - | - | - | - | 1件: 46 46 |
144 | Ro 723-4292/F02 | - | - | - | - | 1件: 8 8 |
145 | Ro Actemra | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
146 | Ro-47-0203 | - | - | - | - | 1件: 86 86 |
147 | Ro-47-0203/029 | - | - | - | - | 1件: 86 86 |
148 | RO-496-4913 | - | - | - | - | 1件: 46 46 |
149 | Ro-Actemra | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 46 46, 107 |
150 | RO001-9265/F04 | - | - | - | - | 1件: 46 46 |
151 | RO0029893 | - | - | - | - | 1件: 46 46 |
152 | RO0220912 | - | - | - | - | 1件: 85 85 |
153 | RO0280296 | - | - | - | - | 1件: 85 85 |
154 | RO045-2294 | - | - | - | - | 1件: 46 46 |
155 | RO0452294/V01 | - | - | - | - | 2件: 43 43, 44 |
156 | RO0452294/V02 | - | - | - | - | 3件: 35 35, 43, 44 |
157 | RO0485337 | - | - | - | - | 1件: 222 222 |
158 | RO04877533 | - | - | - | - | 1件: 46 46 |
159 | RO04877533/F05/F04 | - | - | - | - | 1件: 46 46 |
160 | RO0506997 | - | - | - | - | 2件: 13 13, 46 |
161 | Ro106-1443 | - | - | - | - | 1件: 43 43 |
162 | RO1061443/F02 | - | - | - | - | 1件: 35 35 |
163 | RO3300074 | - | - | - | - | 1件: 231 231 |
164 | RO4402257 | - | - | - | - | 1件: 46 46 |
165 | Ro45-2294 | - | - | - | - | 1件: 271 271 |
166 | RO452294/V02 | - | - | - | - | 1件: 46 46 |
167 | Ro47-0203 | - | - | - | - | 1件: 86 86 |
168 | Ro47-0203 / ACT-050088 | - | - | - | - | 2件: 51 51, 86 |
169 | Ro487-7533 | - | - | - | - | 1件: 46 46 |
170 | RO487-7533/F01-F05 | - | - | - | - | 1件: 46 46 |
171 | RO487-7533/F10-04 | - | - | - | - | 2件: 46 46, 51 |
172 | RO4877533 | - | - | - | - | 2件: 46 46, 107 |
173 | RO4877533 (TCZ) | - | - | - | - | 2件: 46 46, 107 |
174 | RO4877533/F01 | - | - | - | - | 1件: 46 46 |
175 | RO4877533/F04-F05 | - | - | - | - | 1件: 46 46 |
176 | RO4917523 | - | - | - | - | 1件: 206 206 |
177 | RO4917523 0.5 mg | - | - | - | - | 1件: 206 206 |
178 | RO4917523 1.5 mg | - | - | - | - | 1件: 206 206 |
179 | RO496-4913 | - | - | - | - | 1件: 46 46 |
180 | RO4964913 | - | - | - | - | 1件: 13 13 |
181 | RO4964913 F07 | - | - | - | - | 1件: 13 13 |
182 | RO4964913/F03 | - | - | - | - | 1件: 13 13 |
183 | RO4964913/F07 | - | - | - | - | 1件: 13 13 |
184 | RO4964913/F07-01 | - | - | - | - | 1件: 13 13 |
185 | RO5072759 | - | - | - | - | 1件: 222 222 |
186 | RO5333787 | - | - | - | - | 2件: 11 11, 13 |
187 | RO545-9072/F03 | - | - | - | - | 1件: 53 53 |
188 | RO5459072 | - | - | - | - | 1件: 53 53 |
189 | Ro549-0261/F04-02 | - | - | - | - | 1件: 96 96 |
190 | RO5490255 | - | - | - | - | 1件: 85 85 |
191 | RO5490255/F01-02 | - | - | - | - | 1件: 85 85 |
192 | RO5490261 / F02 | - | - | - | - | 1件: 97 97 |
193 | RO5490261/F02 | - | - | - | - | 1件: 97 97 |
194 | RO5490261/F04-02 | - | - | - | - | 1件: 97 97 |
195 | RO5534262 EMICIZUMAB | 1件: Emicizumab Emicizumab | 1件: D10821
D10821
| 2件: F10 F10, F9 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 |
196 | RO6885247 | - | - | - | - | 1件: 3 3 |
197 | RO6885247/F02 | - | - | - | - | 1件: 3 3 |
198 | RO6885247/F03 | - | - | - | - | 1件: 3 3 |
199 | RO7010939 | - | - | - | - | 2件: 13 13, 46 |
200 | RO7010939/F13 | - | - | - | - | 1件: 49 49 |
201 | RO7021610 | - | - | - | - | 1件: 97 97 |
202 | RO7034067 | - | - | - | - | 1件: 3 3 |
203 | RO7034067 / F12 | - | - | - | - | 1件: 3 3 |
204 | RO7034067 / F13 | - | - | - | - | 1件: 3 3 |
205 | RO7034067/F06 + solvente (RO | - | - | - | - | 1件: 3 3 |
206 | RO7034067/F06 with solvent (RO7034067/F08) | - | - | - | - | 1件: 3 3 |
207 | RO7034067/F07 + solvente (RO | - | - | - | - | 1件: 3 3 |
208 | RO7034067/F07 with solvent (RO7034067/F09) | - | - | - | - | 1件: 3 3 |
209 | RO7034067/F12 | - | - | - | - | 1件: 3 3 |
210 | RO7034067/F13 | - | - | - | - | 1件: 3 3 |
211 | RO7046015 | - | - | - | - | 1件: 6 6 |
212 | RO7046015/PRASINEZUMAB | 1件: Prasinezumab Prasinezumab | 1件: D11420
D11420
| 1件: SNCA SNCA 💬 | 3件: Alzheimer disease Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬 | 1件: 6 6 |
213 | RO7049665 | - | - | - | - | 2件: 95 95, 97 |
214 | RO7049665/IgG-IL2/ IgG-IL2ND2 | - | - | - | - | 1件: 95 95 |
215 | RO7090919 | - | - | - | - | 1件: 3 3 |
216 | RO7112689 | - | - | - | - | 1件: 62 62 |
217 | RO7112689/F01 | - | - | - | - | 1件: 62 62 |
218 | RO7112689/F03-01 | - | - | - | - | 2件: 62 62, 109 |
219 | RO7112689/F03-03 | - | - | - | - | 1件: 62 62 |
220 | RO7112689/F03-10 | - | - | - | - | 2件: 62 62, 109 |
221 | RO7123520 | - | - | - | - | 1件: 46 46 |
222 | RO7123520/F03-01 | - | - | - | - | 1件: 46 46 |
223 | RO7204239 | - | - | - | - | 1件: 3 3 |
224 | RO7204239/F01-01 | - | - | - | - | 1件: 3 3 |
225 | RO7234292 | - | - | - | - | 1件: 8 8 |
226 | RO7234292 (RG6042) | - | - | - | - | 1件: 8 8 |
227 | RO7239361 | - | - | - | - | 1件: 113 113 |
228 | RO7239361 (BMS-986089) | - | - | - | - | 1件: 113 113 |
229 | RO7239361 Injections, 15 mg/Syringe (21.4 mg/mL) | - | - | - | - | 1件: 113 113 |
230 | RO7239361 Injections, 35 mg/Syringe (50 mg/mL) | - | - | - | - | 1件: 113 113 |
231 | RO7239361 Injections, 50 mg/Syringe (71.4 mg/mL) | - | - | - | - | 1件: 113 113 |
232 | RO7239361 Injections, 7.5 mg/Syringe (10.7 mg/mL) | - | - | - | - | 1件: 113 113 |
233 | RO7246311 | - | - | - | - | 1件: 97 97 |
234 | RO7248824 | - | - | - | - | 1件: 201 201 |
235 | RO7248824/F02-01 | - | - | - | - | 1件: 201 201 |
236 | RO7248824/F03-01 (Diluent for RO7248824/F02-01 | - | - | - | - | 1件: 201 201 |
237 | RO7490677 | - | - | - | - | 1件: 85 85 |
238 | RO7490677/ F01-02 | - | - | - | - | 1件: 85 85 |
239 | RO7490677/F01-01 | - | - | - | - | 1件: 85 85 |
240 | RO7490677/F01-02 | - | - | - | - | 1件: 85 85 |
241 | RO7490677/F01-03 | - | - | - | - | 1件: 85 85 |
242 | RoActemra | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 11件: 40 40, 41, 44, 46, 50, 51, 86, 107, 266, 271, 331 |
243 | RoActemra (R) | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
244 | ROACTEMRA - 162 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA 0,9ML (VETRO) - 4 SIRINGHE PRERIEMPITE | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 51 51 |
245 | ROACTEMRA - 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 4ML 1 FLACONCINO | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
246 | RoActemra 162 mg | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 46 46, 51 |
247 | RoActemra 162 mg solution for injection in pre-filled syringe | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 41 41 |
248 | RoActemra 162 mg solution injectable en seringue préremplie | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
249 | RoActemra 162 mg soluzione iniettabile in siringa preriempita | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 50 50 |
250 | RoActemra 20 mg/ml concentrado para solución para perfusión | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
251 | RoActemra 20 mg/ml Concentrate for solution for infusion | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
252 | RoActemra 20 mg/ml concentrate for solution for infusion. | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
253 | ROACTEMRA 20 mg/ml, concentrado para solución para perfusión | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 3件: 46 46, 107, 271 |
254 | RoActemra 20mg/ml | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 40 40 |
255 | RoActemra(R) | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
256 | RoActemra/Actemra (tocilizumab) | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 107 107 |
257 | RoActemra® | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 46 46, 271 |
258 | RoActemra® 20mg/ml Konzentrat | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 266 266 |
259 | RoActemra®EV Product Code: PRD82321 | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
260 | RoActerma | - | - | - | - | 1件: 46 46 |
261 | RoActmera | - | - | - | - | 1件: 46 46 |
262 | Rob 803 | - | - | - | - | 1件: 46 46 |
263 | Rob 803 (9-Chloro-2,3-dimethyl-6-(N,N-dimethylaminoethylamino-2-oxoethyl)-6H-indolo[2,3-b] quinoxali | - | - | - | - | 1件: 46 46 |
264 | Rob 803 (capsules 12.5 mg) | - | - | - | - | 1件: 46 46 |
265 | Rob 803 (capsules 15 mg) | - | - | - | - | 1件: 46 46 |
266 | Rob 803 (capsules 25 mg) | - | - | - | - | 1件: 46 46 |
267 | Rob 803 (capsules 6.25 mg) | - | - | - | - | 1件: 46 46 |
268 | Rob 803 12.5mg capsule | - | - | - | - | 1件: 46 46 |
269 | Rob 803 15mg capsule | - | - | - | - | 1件: 46 46 |
270 | Rob 803 25mg capsule | - | - | - | - | 1件: 46 46 |
271 | Rob 803 6.25mg capsule | - | - | - | - | 1件: 46 46 |
272 | Rob 803 6.5mg capsule | - | - | - | - | 1件: 46 46 |
273 | Rocuronium | 1件: Rocuronium Rocuronium | 1件: D00765
D00765
(Name: Rocuronium bromide) | 16件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB2, CHRNB3, CHRNB4 💬 | 15件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 296 296 |
274 | Rodatristat ethyl | - | - | - | - | 1件: 86 86 |
275 | Rodatristat Ethyl 300 mg tablet | - | - | - | - | 1件: 86 86 |
276 | Rofecoxib | 1件: Rofecoxib Rofecoxib | 1件: D00568
D00568
(Name: Rofecoxib) | 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
277 | Roferon-A | 1件: Interferon alfa-2a Interferon alfa-2a (Synonym: Roferon A Sterile Pws 18m Unit/vial) | 1件: D00745
D00745
(Name: Roferon A (TN)) | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 56 56 |
278 | Roferon-A 3miu | 1件: Interferon alfa-2a Interferon alfa-2a (Synonym: Roferon A Sterile Pws 18m Unit/vial) | 1件: D00745
D00745
(Name: Roferon A (TN)) | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 56 56 |
279 | Roferon-A, 3miu | 1件: Interferon alfa-2a Interferon alfa-2a (Synonym: Roferon A Sterile Pws 18m Unit/vial) | 1件: D00745
D00745
(Name: Roferon A (TN)) | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 56 56 |
280 | Roferon-A, 4.5miu | 1件: Interferon alfa-2a Interferon alfa-2a (Synonym: Roferon A Sterile Pws 18m Unit/vial) | 1件: D00745
D00745
(Name: Roferon A (TN)) | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 56 56 |
281 | Roferon-A, 6miu | 1件: Interferon alfa-2a Interferon alfa-2a (Synonym: Roferon A Sterile Pws 18m Unit/vial) | 1件: D00745
D00745
(Name: Roferon A (TN)) | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 56 56 |
282 | Roflumilast | 1件: Roflumilast Roflumilast | 1件: D05744
D05744
(Name: Roflumilast) | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 2件: 84 84, 299 |
283 | Roflumilast Oral Tablet | 1件: Roflumilast Roflumilast | 1件: D05744
D05744
(Name: Roflumilast) | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 299 299 |
284 | Rokan (r) Novo 120 mg | - | - | - | - | 1件: 18 18 |
285 | Rolipram | 1件: Rolipram Rolipram | 1件: D01783
D01783
(Name: Rolipram) | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 2件: 8 8, 13 |
286 | Romiplostim | 1件: Romiplostim Romiplostim | 1件: D08990
D08990
(Name: Romiplostim) | 1件: MPL MPL 💬 | 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 4件: 60 60, 63, 64, 65 |
287 | Romiplostin | - | - | - | - | 1件: 63 63 |
288 | ROMOSOZUMAB | 1件: Romosozumab Romosozumab | 1件: D10156
D10156
(Name: Romosozumab) | 1件: SOST SOST 💬 | 2件: Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action, Wnt signaling pathway 💬 | 1件: 274 274 |
289 | Rontalizumab | 1件: Rontalizumab Rontalizumab | 1件: D09662
D09662
(Name: Rontalizumab) | 13件: IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 | 25件: Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 49 49 |
290 | ROP | - | - | - | - | 1件: 6 6 |
291 | ROP+L-Dopa | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
292 | ROPINIROLE | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 6 6, 74, 309 |
293 | Ropinirole (as hydrochloride) | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
294 | Ropinirole controlled-release (REQUIP CR) for RLS | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
295 | Ropinirole CR 2mg tablet | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
296 | Ropinirole CR 8mg tablet | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
297 | Ropinirole Hydrochloride | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 309 |
298 | Ropinirole hydrochloride extended-release tablet | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
299 | Ropinirole hydrochloride extended-release tablet placebo | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
300 | Ropinirole hydrochloride prolonged release | 2件: Manganese citrate Manganese citrate, Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
301 | Ropinirole immediate release | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
302 | Ropinirole Implant | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
303 | Ropinirole IR | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
304 | Ropinirole IR Tablets | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
305 | Ropinirole monotherapy | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
306 | Ropinirole oral product | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
307 | Ropinirole PR | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
308 | Ropinirole PR, 2mg | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
309 | Ropinirole PR/XR | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
310 | Ropinirole PR/XR Tablets | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
311 | Ropinirole Prolonged release | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
312 | Ropinirole prolonged release/extended release(PR/XR) | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
313 | Ropinirole XL | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
314 | Ropinirole XL (formerly CR) | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
315 | Ropinirole/L-dopa | 2件: Levodopa Levodopa, Ropinirole | 3件: D00059
D00059
,
D00784
(Name: Ropinirole hydrochloride),
D08489
(Name: Ropinirole) | 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
316 | Ropivacaine | 1件: Ropivacaine Ropivacaine | 2件: D04048
D04048
(Name: Ropivacaine hydrochloride),
D08490
(Name: Ropivacaine) | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 3件: 36 36, 46, 70 |
317 | Ropivacaine plus normal saline | 1件: Ropivacaine Ropivacaine | 2件: D04048
D04048
(Name: Ropivacaine hydrochloride),
D08490
(Name: Ropivacaine) | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 70 70 |
318 | Roscovitine | - | - | - | - | 1件: 299 299 |
319 | Rosemary | 1件: Rosemary Rosemary | - | - | - | 1件: 51 51 |
320 | Rosiglitazone | 1件: Rosiglitazone Rosiglitazone | 2件: D00596
D00596
(Name: Rosiglitazone maleate),
D08491
(Name: Rosiglitazone) | 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 5件: 46 46, 75, 97, 222, 265 |
321 | Rosiglitazone (Avandia) | 1件: Rosiglitazone Rosiglitazone | 2件: D00596
D00596
(Name: Rosiglitazone maleate),
D08491
(Name: Rosiglitazone) | 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 222 222 |
322 | Rosiglitazone Extended Release Tablets | 1件: Rosiglitazone Rosiglitazone | 2件: D00596
D00596
(Name: Rosiglitazone maleate),
D08491
(Name: Rosiglitazone) | 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 46 46 |
323 | Rosiglitazone maleate | 1件: Rosiglitazone Rosiglitazone | 2件: D00596
D00596
(Name: Rosiglitazone maleate),
D08491
(Name: Rosiglitazone) | 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 3件: 46 46, 75, 265 |
324 | Rosiglitazone XR | 1件: Rosiglitazone Rosiglitazone | 2件: D00596
D00596
(Name: Rosiglitazone maleate),
D08491
(Name: Rosiglitazone) | 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 46 46 |
325 | Rosuvastatin | 1件: Rosuvastatin Rosuvastatin | 2件: D01915
D01915
(Name: Rosuvastatin calcium),
D08492
(Name: Rosuvastatin) | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 11件: 6 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 |
326 | Rosuvastatin 10 mg | 1件: Rosuvastatin Rosuvastatin | 2件: D01915
D01915
(Name: Rosuvastatin calcium),
D08492
(Name: Rosuvastatin) | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 96 96 |
327 | Rosuvastatin 10mg | 1件: Rosuvastatin Rosuvastatin | 2件: D01915
D01915
(Name: Rosuvastatin calcium),
D08492
(Name: Rosuvastatin) | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 97 97 |
328 | Rosuvastatin 20mg | 1件: Rosuvastatin Rosuvastatin | 2件: D01915
D01915
(Name: Rosuvastatin calcium),
D08492
(Name: Rosuvastatin) | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 79 79 |
329 | ROSUVASTATIN CALCIUM | 2件: Calcium Calcium (Synonym: Multi Rol), Rosuvastatin | 2件: D01915
D01915
(Name: Rosuvastatin calcium),
D08492
(Name: Rosuvastatin) | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 4件: 49 49, 79, 97, 299 |
330 | Rosuvastatin calcium 40mg | 2件: Calcium Calcium (Synonym: Multi Rol), Rosuvastatin | 2件: D01915
D01915
(Name: Rosuvastatin calcium),
D08492
(Name: Rosuvastatin) | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 56 56 |
331 | Rosuvastatine EG | - | - | - | - | 1件: 97 97 |
332 | ROT-TDS 8 mg/24 h | - | - | - | - | 1件: 6 6 |
333 | Rotigotin | - | - | - | - | 1件: 6 6 |
334 | ROTIGOTINA | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
335 | ROTIGOTINE | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 127 |
336 | Rotigotine (Reference product PR 2.1.1) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
337 | Rotigotine (Test product PR 2.3.1) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
338 | Rotigotine 4Mg/24Hrs Patch | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 127 127 |
339 | Rotigotine 6Mg/24Hrs Patch | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 127 127 |
340 | Rotigotine hydrochloride | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
341 | Rotigotine Nasal Spray | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
342 | Rotigotine transdermal patch | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
343 | Rotigotine transdermal patch 2mg/24h(10cm2) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
344 | Rotigotine transdermal patch 4mg/24h (20cm2) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
345 | Rotigotine transdermal patch 6mg/24h (30cm2) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
346 | Rotigotine transdermal patch 8mg/24h (40cm2) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
347 | Rotigotine TTS (Test) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
348 | Rotigotine, extended-release microspheres | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
(Name: Rotigotine) | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
349 | Routine drainage surgery | - | - | - | - | 1件: 96 96 |
350 | Routine steroid administration group | - | - | - | - | 1件: 85 85 |
351 | Routine transdermal oestrogen patch | - | - | - | - | 1件: 78 78 |
352 | Routine Treatment of CD | - | - | - | - | 1件: 96 96 |
353 | Roxithromycin | 1件: Roxithromycin Roxithromycin | 1件: D01710
D01710
(Name: Roxithromycin) | - | - | 2件: 46 46, 299 |
354 | Royal jelly | 1件: Royal jelly Royal jelly | 1件: D09754
D09754
(Name: Royal jelly) | - | - | 1件: 49 49 |
355 | ROZANOLIXIZUMAB | 1件: Rozanolixizumab Rozanolixizumab | 1件: D12182
D12182
(Name: Rozanolixizumab) | 1件: FCGRT FCGRT 💬 | - | 3件: 11 11, 14, 63 |
356 | ROZEREM | 1件: Ramelteon Ramelteon (Synonym: Rozerem) | 1件: D02689
D02689
(Name: Rozerem (TN)) | 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
357 | Rozibafusp Alfa | - | - | - | - | 1件: 49 49 |
358 | Satralizumab (RO5333787/Enspryng /SA237) | 1件: Satralizumab Satralizumab | 1件: D11079
D11079
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 |
359 | Satralizumab (RO5333787/Enspryng/SA237) | 1件: Satralizumab Satralizumab | 1件: D11079
D11079
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 |
360 | Satralizumab (RO5333787/SA237) | 1件: Satralizumab Satralizumab | 1件: D11079
D11079
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 |
361 | Satrazlizumab (RO5333787/ Enspryng /SA237) | 1件: Satralizumab Satralizumab | 1件: D11079
D11079
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 |
362 | Selective Nerve Root Block | - | - | - | - | 1件: 70 70 |
363 | SODIUM ACID PYROPHOSPHATE SAPP ROR 28 FOOD GRADE | - | - | - | - | 1件: 166 166 |
364 | SPD476 (mesalazine) (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
365 | SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine (Synonym: Rowasa (TN)) | 1件: Mesalazine Mesalazine (Synonym: Rowasa) | 1件: D00377
D00377
(Name: Rowasa (TN)) | - | - | 1件: 97 97 |
366 | Standardized turmeric root extract | 1件: Turmeric Turmeric (Synonym: Curcuma Longa Root Dry Extract) | - | - | - | 1件: 299 299 |
367 | Takecab tablets + amoxicillin + clarithromycin (first-line eradication) Takecab tablets + amoxicillin + metronidazole (second-line eradication) (Synonym: ROSADAN) | 3件: Amoxicillin Amoxicillin, Clarithromycin, Metronidazole (Synonym: Rosaclear System) | 7件: D00229
D00229
,
D00276
,
D00409
(Name: ROSADAN),
D02925
,
D05016
,
D05017
,
D07452
| - | - | 1件: 63 63 |
368 | Tocilizumab (Actemra or RoActemra) | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
369 | Tocilizumab [RoActemra/Actemra] | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 4件: 46 46, 51, 107, 331 |
370 | Tocilizumab [RoActemra] | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
371 | Tocilizumab Infusion RoAcemtra (EU) | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 266 266 |
372 | Tocilizumab Roche | 1件: Tocilizumab Tocilizumab (Synonym: Roactemra) | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 46 46, 107 |
373 | Tolicizumab Roche | - | - | - | - | 1件: 46 46 |
374 | Traditional Chinese Medicinal Mixture (composed of Roucongrong and adjuvant) | - | - | - | - | 1件: 6 6 |
375 | Tramadol with ropivacaine | 2件: Ropivacaine Ropivacaine, Tramadol | 4件: D01355
D01355
,
D04048
(Name: Ropivacaine hydrochloride),
D08490
(Name: Ropivacaine),
D08623
| 6件: OPRM1 OPRM1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 6件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction 💬 | 1件: 70 70 |
376 | Transdermal flumazenil (Added 4/2020) (Synonym: Romazicon (TN)) | 1件: Flumazenil Flumazenil (Synonym: Romazicon) | 1件: D00697
D00697
(Name: Romazicon (TN)) | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 6 6 |
377 | Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere | 1件: Dulaglutide Dulaglutide | 1件: D09889
D09889
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 13 13 |
378 | Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere. | 1件: Dulaglutide Dulaglutide | 1件: D09889
D09889
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 13 13 |
379 | UTTR1147A/RO7021610 (Active) | - | - | - | - | 2件: 96 96, 97 |